Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples